These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 23456497)
1. Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma. Zhang J; Yang X; Wang Y; Shi H; Guan C; Yao L; Huang X; Ding Z; Huang Y; Wang H; Cheng C Dig Dis Sci; 2013 Jul; 58(7):2028-37. PubMed ID: 23456497 [TBL] [Abstract][Full Text] [Related]
2. Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression. Zhang J; Zhu J; Yang L; Guan C; Ni R; Wang Y; Ji L; Tian Y Tumour Biol; 2015 Sep; 36(9):6701-14. PubMed ID: 25820824 [TBL] [Abstract][Full Text] [Related]
3. PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma. Ni S; Chen L; Li M; Zhao W; Shan X; Wu M; Cheng J; Liang L; Wang Y; Jiang W; Zhang J; Ni R Tumour Biol; 2016 Oct; 37(10):13799-13809. PubMed ID: 27481515 [TBL] [Abstract][Full Text] [Related]
4. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis. Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810 [TBL] [Abstract][Full Text] [Related]
5. CDK7 and CCNH are components of CDK-activating kinase and are required for meiotic progression of pig oocytes. Fujii W; Nishimura T; Kano K; Sugiura K; Naito K Biol Reprod; 2011 Dec; 85(6):1124-32. PubMed ID: 21778139 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma. Zeng H; Yang H; Song Y; Fang D; Chen L; Zhao Z; Wang C; Xie S Cell Death Dis; 2021 Nov; 12(11):1048. PubMed ID: 34741018 [TBL] [Abstract][Full Text] [Related]
7. Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration. Wang Y; Liu F; Mao F; Hang Q; Huang X; He S; Wang Y; Cheng C; Wang H; Xu G; Zhang T; Shen A J Biol Chem; 2013 Mar; 288(13):9028-34. PubMed ID: 23393140 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma. Jiang L; Huang R; Wu Y; Diao P; Zhang W; Li J; Li Z; Wang Y; Cheng J; Yang J Pathology; 2019 Jan; 51(1):74-80. PubMed ID: 30473182 [TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of cyclin H and CDK7 in human hemangiomas]. Liu J; Zhang DL; Shan SG Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Jul; 24(4):300-2. PubMed ID: 18950027 [TBL] [Abstract][Full Text] [Related]
10. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules. Lai KK; Chan KT; Choi MY; Wang HK; Fung EY; Lam HY; Tan W; Tung LN; Tong DK; Sun RW; Lee NP; Law S Tumour Biol; 2016 Feb; 37(2):2127-36. PubMed ID: 26346170 [TBL] [Abstract][Full Text] [Related]
11. CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A. Guan C; Shi H; Wang H; Zhang J; Ni W; Chen B; Hou S; Yang X; Shen A; Ni R J Cell Biochem; 2013 Jun; 114(6):1343-54. PubMed ID: 23255392 [TBL] [Abstract][Full Text] [Related]
12. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest. Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693 [TBL] [Abstract][Full Text] [Related]
13. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma. Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660 [TBL] [Abstract][Full Text] [Related]
14. Cyclin H Regulates Lung Cancer Progression as a Carcinoma Inducer. Mao L; Ling X; Chen J Comput Math Methods Med; 2021; 2021():6646077. PubMed ID: 33777168 [TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo]. Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma. Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470 [TBL] [Abstract][Full Text] [Related]
17. Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro. Cheng Y; Li K; Diao D; Zhu K; Shi L; Zhang H; Yuan D; Guo Q; Wu X; Liu D; Dang C Lab Invest; 2013 Dec; 93(12):1276-87. PubMed ID: 24145239 [TBL] [Abstract][Full Text] [Related]
18. Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells. Liu WX; Liu XY; Yu H; Chen Y; Hao Q Mol Med Rep; 2015 Mar; 11(3):1745-51. PubMed ID: 25411854 [TBL] [Abstract][Full Text] [Related]
19. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma. Liu X; Ma W; Yan Y; Wu S J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995 [TBL] [Abstract][Full Text] [Related]
20. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway. Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]